Study endpoints
MOVEMENT DISORDER, SECONDARY
The primary endpoint was the change in MDS-UPDRS Part III total score from baseline at 24 weeks. The secondary endpoints included the total score and sub-items in MDS-UPDRS Part II and III [Efficacy and safety endpoints, except for AEs and ADRs, were evaluated by a third party (e.g., physician or clinical psychologist, physiotherapist) other than the principal investigator in charge of each patient. The MDS-UPDRS Part III was evaluated by a third party (e.g., physician, clinical psychologist, physical therapist) who had been certified by the e-learning course developed by the Movement Disorder Society.